Kazufumi Dohmen

2.9k total citations
96 papers, 2.0k citations indexed

About

Kazufumi Dohmen is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Kazufumi Dohmen has authored 96 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hepatology, 48 papers in Epidemiology and 18 papers in Surgery. Recurrent topics in Kazufumi Dohmen's work include Liver Disease Diagnosis and Treatment (40 papers), Hepatitis C virus research (32 papers) and Hepatitis B Virus Studies (19 papers). Kazufumi Dohmen is often cited by papers focused on Liver Disease Diagnosis and Treatment (40 papers), Hepatitis C virus research (32 papers) and Hepatitis B Virus Studies (19 papers). Kazufumi Dohmen collaborates with scholars based in Japan, United States and France. Kazufumi Dohmen's co-authors include Hiromi Ishibashi, Enrique Baraona, Gabriele Pozzato, Zev W. Chayes, Michelle Moretti, Chaim S. Abittan, Charles S. Lieber, Makoto Nakamuta, Marina Afanasyeva and Ziya Kaya and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kazufumi Dohmen

87 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazufumi Dohmen Japan	24	1.1k	913	333	260	242	96	2.0k
Anja Victor Germany	21	580 0.5×	427 0.5×	116 0.3×	309 1.2×	331 1.4×	53	1.7k
Naoko Kono Japan	32	529 0.5×	436 0.5×	457 1.4×	339 1.3×	645 2.7×	121	3.1k
P Attali France	26	595 0.5×	631 0.7×	310 0.9×	62 0.2×	491 2.0×	79	2.5k
Christine Silvain France	27	998 0.9×	1.1k 1.2×	216 0.6×	205 0.8×	822 3.4×	104	2.3k
Pierre Blanc France	29	880 0.8×	936 1.0×	237 0.7×	73 0.3×	1.1k 4.6×	161	2.7k
Hisamitsu Miyaaki Japan	24	965 0.9×	994 1.1×	115 0.3×	118 0.5×	393 1.6×	145	2.1k
Michael Adler Belgium	30	1.8k 1.7×	1.7k 1.9×	282 0.8×	57 0.2×	716 3.0×	81	3.1k
Naota Taura Japan	22	847 0.8×	726 0.8×	71 0.2×	87 0.3×	294 1.2×	87	1.6k
Steven Masson United Kingdom	23	1.2k 1.1×	706 0.8×	575 1.7×	94 0.4×	292 1.2×	84	2.0k
Suzanne Norris Ireland	31	1.2k 1.2×	1.4k 1.6×	74 0.2×	1.2k 4.5×	335 1.4×	110	3.2k

Countries citing papers authored by Kazufumi Dohmen

Since Specialization

Citations

This map shows the geographic impact of Kazufumi Dohmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazufumi Dohmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazufumi Dohmen more than expected).

Fields of papers citing papers by Kazufumi Dohmen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazufumi Dohmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazufumi Dohmen. The network helps show where Kazufumi Dohmen may publish in the future.

Co-authorship network of co-authors of Kazufumi Dohmen

This figure shows the co-authorship network connecting the top 25 collaborators of Kazufumi Dohmen. A scholar is included among the top collaborators of Kazufumi Dohmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazufumi Dohmen. Kazufumi Dohmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ogawa, Eiichi, Motoyuki Kohjima, Toshimasa Koyanagi, et al.. (2025). Five‐Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment. Journal of Gastroenterology and Hepatology. 40(10). 2560–2567.

Dohmen, Kazufumi, et al.. (2021). Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis. SHILAP Revista de lepidopterología. 78(4). 227–234. 10 indexed citations

Ogawa, Eiichi, Hideyuki Nomura, Makoto Nakamuta, et al.. (2020). Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B. Liver International. 40(7). 1578–1589. 37 indexed citations

Ogawa, Eiichi, Norihiro Furusyo, Eiji Kajiwara, et al.. (2015). Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non‐cirrhotic patients with chronic hepatitis C virus genotype 1b infection. Journal of Gastroenterology and Hepatology. 30(12). 1759–1767. 8 indexed citations

Dohmen, Kazufumi, Akira Kawano, Kazuhiro Takahashi, et al.. (2014). The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C.. PubMed. 60(128). 2034–8. 12 indexed citations

Shimoda, Shinji, Hironori Tanimoto, Hideyuki Nomura, et al.. (2013). Interferon-α-Induced Changes to Natural Killer Cells Are Associated with the Treatment Outcomes in Patients with HCV Infections. PubMed. 2013. 1–7. 2 indexed citations

Dohmen, Kazufumi, et al.. (2013). A case of vanishing bile duct syndrome complicated with toxic epidermal necrolysis performed liver biopsy three times subsequently. Kanzo. 54(1). 67–73.

Dohmen, Kazufumi, et al.. (2013). A case of amoebic liver abscess that developed during triple therapy for chronic hepatitis C. Kanzo. 54(11). 787–795.

Dohmen, Kazufumi, et al.. (2011). Molecular epidemiological analysis of hepatitis A virus strain separated in Fukuoka 2010-the similarity with the strain from a patient infected in Borneo (Kalimantan) island 1999. Kanzo. 52(8). 497–502. 1 indexed citations

10.

Ogawa, Eiichi, Norihiro Furusyo, Eiji Kajiwara, et al.. (2011). Evaluation of the adverse effect of premature discontinuation of pegylated interferon α‐2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study. Journal of Gastroenterology and Hepatology. 27(7). 1233–1240. 29 indexed citations

11.

Dohmen, Kazufumi, et al.. (2010). A case of autoimmune hepatitis/primary biliary cirrhosis overlap syndrome progressing rapidly to cirrhosis with skin pigmentation and various immunological characteristics. Kanzo. 51(9). 513–520.

12.

Dohmen, Kazufumi, Norihiko Kubo, Hirofumi Tanaka, et al.. (2009). Complete response to treatment with hepatic arterial chemoembolization and arterial infusion chemotherapy in a case of hepatocellular carcinoma with multiple lung metastases. Kanzo. 50(4). 201–207.

13.

Dohmen, Kazufumi, et al.. (2008). Three cases of amoebic liver abscess. Kanzo. 49(6). 260–267. 2 indexed citations

14.

Dohmen, Kazufumi, et al.. (2008). A Crohn's disease patient who developed nonalcoholic steatosis and cirrhosis of the liver after surgical excision of the small intestines. Kanzo. 49(8). 368–375. 1 indexed citations

15.

Dohmen, Kazufumi, et al.. (2008). A patient with chronic hepatitis C who did, and another who did not develop type 1 diabetes mellitus during interferon therapy: ironically the pre-treatment anti-GAD antibody was positive only in the latter. Kanzo. 49(2). 58–64. 1 indexed citations

16.

Kaya, Ziya, Kazufumi Dohmen, Yan Wang, et al.. (2002). Cutting Edge: A Critical Role for IL-10 in Induction of Nasal Tolerance in Experimental Autoimmune Myocarditis. The Journal of Immunology. 168(4). 1552–1556. 61 indexed citations

17.

Dohmen, Kazufumi, et al.. (1999). Chronic hepatitis C associated with porphyria cutanea tarda which showed hepatic focal fatty change arising in a non-alcoholic patient.. Kanzo. 40(6). 350–354. 3 indexed citations

18.

Matsunaga, Takashi, Jiro Kudo, Kazuhiro Takahashi, et al.. (1996). Rotenone, a mitochondrial NADH dehydrogenase inhibitor, induces cell surface expression of CD 13 and CD38 and apoptosis in HL-60 cells. Leukemia & lymphoma. 20(5-6). 487–494. 24 indexed citations

19.

Dohmen, Kazufumi, et al.. (1991). A case of adult T-cell leukemia (ATL) manifested as acute hepatic failure. Demonstration of histological changes of the liver at the onset and the death.. Kanzo. 32(12). 1156–1162. 2 indexed citations

20.

Dohmen, Kazufumi, et al.. (1989). A case of primary biliary cirrhosis associated with mixed connective tissue disease.. Kanzo. 30(8). 919–923. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact